Many Non-Antibiotic Drugs Affect Gut Bacteria

A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAID

Antibiotics are known to influence the growth of bacteria in the human body. But new research led by a team at the European Molecular Biology Laboratory (EMBL) in Germany suggests that more than 200 non-antibiotic medicines with human-cell targets, from anti-inflammatory drugs to antipsychotic compounds, can also trigger changes. The findings were published yesterday (March 19) in Nature.

To explore the microbiome’s response to non-antibiotic drugs, the researchers individually tested nearly 1,200 medications—835 of which have human-cell targets—on 38 species of gut bacteria in vitro. The team found that around a quarter of medications with human targets, and 27 percent of the drugs over all, at least partially inhibited growth in one or more of the bacteria species. “For us, that was much more than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours